More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA.

More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA. by Jones RN, Sader HS, Flamm RK and Watters AA published in Diagn. Microbiol. Infect. Dis. 2013; 76 (1): 110-112